U.S. federal trademark · Serial No. 74730497
consulting services, namely, developing therapeutic strategies using pharmaceuticals and drugs for others
pharmaceuticals, namely, nitric oxide synthase inhibitors for the treatment of emesis, nausea, anxiety and schizophrenia
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.